+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 103 Pages
  • December 2022
  • Region: Global
  • GlobalData
  • ID: 5714504
The publisher's Medical Devices sector report, “Dental Bone Graft Substitutes & Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Dental Bone Graft Substitutes & Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease or developmental deficiency.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dental Bone Graft Substitutes & Regenerative Materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dental Bone Graft Substitutes & Regenerative Materials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dental Bone Graft Substitutes & Regenerative Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Dental Bone Graft Substitutes & Regenerative Materials Overview

3 Products under Development
3.1 Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Stage of Development
3.2 Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Segment
3.3 Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Territory
3.4 Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Regulatory Path
3.5 Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Estimated Approval Date
3.6 Dental Bone Graft Substitutes & Regenerative Materials - Ongoing Clinical Trials

4 Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products under Development by Companies
4.1 Dental Bone Graft Substitutes & Regenerative Materials Companies - Pipeline Products by Stage of Development
4.2 Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Stage of Development

5 Dental Bone Graft Substitutes & Regenerative Materials Companies and Product Overview

6 Dental Bone Graft Substitutes & Regenerative Materials- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer

List of Tables
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Stage of Development
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Segment
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Territory
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Regulatory Path
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Estimated Approval Date
  • Dental Bone Graft Substitutes & Regenerative Materials - Ongoing Clinical Trials
  • Dental Bone Graft Substitutes & Regenerative Materials Companies - Pipeline Products by Stage of Development
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Stage of Development
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Segment
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Territory
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Regulatory Path
  • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Estimated Approval Date
  • Dental Bone Graft Substitutes & Regenerative Materials - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3-D Matrix Ltd
  • Advanced Biotech Products Pvt Ltd
  • Cayman Chemical Co
  • CellSeed Inc
  • Colorado Therapeutics, LLC
  • credentis AG
  • curasan AG
  • Fujifilm Corp
  • Histocell SL
  • Indian Institute of Technology Bombay
  • Induce Biologics Inc.
  • Ivory Graft Ltd
  • Malla Reddy Institute of Medical Sciences
  • Maxigen Biotech Inc
  • Medtronic Plc
  • Nobel Biocare Services AG
  • Novatissue SAS
  • Orthocell Ltd
  • Orthogen LLC
  • Orthorebirth Co Ltd
  • Orthosera GmbH
  • PolyPid Ltd
  • Polytechnic University of Catalonia
  • RevBio Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Straumann Holding AG
  • SurgaColl Technologies Ltd
  • SweetBio, Inc.
  • Tetratherix Pty Ltd
  • Tigran Technologies AB
  • University of Bielefeld
  • University of Connecticut Health Center
  • University of Maryland
  • ZetaGen Therapeutics Inc